01/08/2025 | Press release | Distributed by Public on 01/08/2025 07:01

Cocrystal Pharma Reports Phase 1 Results with Oral, Broad Acting Antiviral Drug CDI 988 for Prophylaxis and Treatment of Norovirus, Coronaviruses and Other Viral Infections

Please select the service you want to use:

• Newsvine
• Digg
• Delicious
• StumbleUpon
• Technorati
• Buzz
• Favorites
• Google Reader

 Back

 Download the original document